Early research (Phase 1)Looking for participantsNCT06917742
What this trial is testing
Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Who this might be right for
Healthy VolunteersRheumatoid ArthritisSystemic Lupus Erythematosus
Capstan Therapeutics 64